CIMAZ, ROLANDO
 Distribuzione geografica
Continente #
NA - Nord America 26.003
EU - Europa 13.645
AS - Asia 7.834
SA - Sud America 1.503
OC - Oceania 278
AF - Africa 273
Continente sconosciuto - Info sul continente non disponibili 4
Totale 49.540
Nazione #
US - Stati Uniti d'America 25.820
RU - Federazione Russa 5.962
SG - Singapore 2.278
HK - Hong Kong 1.814
IE - Irlanda 1.673
PL - Polonia 1.579
CN - Cina 1.351
SE - Svezia 1.350
BR - Brasile 1.288
IT - Italia 1.288
KR - Corea 1.072
FI - Finlandia 491
DE - Germania 381
VN - Vietnam 321
GB - Regno Unito 297
IN - India 282
AU - Australia 276
TR - Turchia 270
UA - Ucraina 171
FR - Francia 163
CI - Costa d'Avorio 127
JO - Giordania 112
CA - Canada 109
ES - Italia 100
AR - Argentina 82
ID - Indonesia 71
CH - Svizzera 55
JP - Giappone 54
BD - Bangladesh 43
IQ - Iraq 42
MX - Messico 40
NL - Olanda 38
ZA - Sudafrica 35
EC - Ecuador 33
MA - Marocco 26
CO - Colombia 21
VE - Venezuela 20
AT - Austria 18
BE - Belgio 17
EG - Egitto 17
SA - Arabia Saudita 17
SC - Seychelles 17
CL - Cile 16
PK - Pakistan 15
PY - Paraguay 15
AZ - Azerbaigian 13
PE - Perù 13
IR - Iran 10
KZ - Kazakistan 10
TN - Tunisia 10
UY - Uruguay 10
UZ - Uzbekistan 10
CZ - Repubblica Ceca 8
LT - Lituania 8
MU - Mauritius 8
BG - Bulgaria 7
RO - Romania 7
BH - Bahrain 6
DO - Repubblica Dominicana 6
KE - Kenya 6
AE - Emirati Arabi Uniti 5
BJ - Benin 5
BO - Bolivia 5
DZ - Algeria 5
GT - Guatemala 5
JM - Giamaica 5
LB - Libano 5
PH - Filippine 5
BN - Brunei Darussalam 4
HN - Honduras 4
HU - Ungheria 4
KG - Kirghizistan 4
NO - Norvegia 4
RS - Serbia 4
BY - Bielorussia 3
CM - Camerun 3
ET - Etiopia 3
LV - Lettonia 3
NG - Nigeria 3
OM - Oman 3
PT - Portogallo 3
TW - Taiwan 3
AL - Albania 2
BB - Barbados 2
CR - Costa Rica 2
EU - Europa 2
IL - Israele 2
KH - Cambogia 2
MD - Moldavia 2
MY - Malesia 2
NP - Nepal 2
PA - Panama 2
QA - Qatar 2
RE - Reunion 2
SN - Senegal 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
CG - Congo 1
Totale 49.520
Città #
Santa Clara 4.247
Fairfield 3.160
Ashburn 1.865
Chandler 1.690
Dublin 1.672
Warsaw 1.575
Hong Kong 1.402
Woodbridge 1.390
Singapore 1.385
Cambridge 1.300
Seattle 1.268
Houston 1.121
Seoul 1.072
Wilmington 1.030
Altamura 787
Lawrence 720
Princeton 645
Beijing 643
Ann Arbor 450
Boston 401
Jacksonville 338
Buffalo 327
Dallas 308
Los Angeles 306
Melbourne 262
Moscow 250
Izmir 239
Boardman 215
Medford 214
Clifton 210
Mumbai 204
San Diego 184
New York 163
Abidjan 127
Hefei 120
Ho Chi Minh City 119
Falls Church 112
Florence 103
Munich 93
Shanghai 82
São Paulo 81
Barcelona 80
Norwalk 80
London 79
Redondo Beach 79
Toronto 63
Hanoi 60
Paris 58
The Dalles 56
Bern 52
Turku 50
Hillsboro 49
Tokyo 46
Yubileyny 45
Andover 43
Jakarta 42
Kent 42
Dong Ket 38
San Jose 37
Milan 35
Rio de Janeiro 35
Pune 34
Belo Horizonte 29
Chicago 29
Frankfurt am Main 27
Guangzhou 27
Curitiba 26
Brasília 25
Philadelphia 25
Brooklyn 24
Tianjin 23
Porto Alegre 21
Columbus 20
Helsinki 20
Council Bluffs 19
Johannesburg 19
Phoenix 19
Salvador 18
Vienna 18
Frankfurt Am Main 16
Brussels 15
Campinas 15
Tappahannock 15
Cairo 14
Dearborn 14
Dhaka 14
Goiânia 14
Montreal 14
San Francisco 14
Stockholm 14
Atlanta 13
Baghdad 13
Baku 13
Laurel 13
Quito 13
Guayaquil 12
Ankara 11
Denver 11
Elk Grove Village 11
Fortaleza 11
Totale 33.652
Nome #
Chitinase 3-like-1 is produced by human Th17 cells and correlates with the level of inflammation in juvenile idiopathic arthritis patients 314
Th1-induced CD106 expression mediates leukocytes adhesion on synovial fibroblasts from juvenile idiopathic arthritis patients 275
First report of circulating microRNAs in tumour necrosis factor receptor-associated periodic syndrome (TRAPS). 271
Expert consensus on dynamics of laboratory tests for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis 256
The intestinal microbiota in enthesitis-related arthitis 253
Alteration of Fecal Microbiota Profiles in Juvenile Idiopathic Arthritis. Associations with HLA-B27 Allele and Disease Status. 247
Managing pediatric osteoporosis 241
Neonatal lupus: clinical features and risk of congenital cardiac heart block in newborns from mothers with anti Ro/SSA antibodies 233
Common symptoms for a rare disease in a girl with sarcoidosis: a case report 221
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study. 218
Disease status, reasons for discontinuation and adverse events in 1038 Italian children with juvenile idiopathic arthritis treated with etanercept 211
T cell subpopulations in juvenile idiopathic arthritis and their modifications after biotherapies 208
Anti-inflammatory and immunosuppressive drugs and reproduction. 205
Distinctive features of classic and non-classic (Th17-derived) human Th1 cells. 205
Anti-adalimumab antibodies in a cohort of patients with juvenile idiopathic arthritis: incidence and clinical correlations 205
Disease activity assessment in childhood vasculitis: development and preliminary validation of the Paediatric Vasculitis Activity Score (PVAS). 204
Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic modifier drug: Adalimumab as starting anti-TNF-alpha therapy in childhood chronic uveitis. 203
Elicitation of expert prior opinion: application to the MYPAN trial in childhood polyarteritis nodosa 202
Rarity of human T helper 17 cells is due to retinoic acid orphan receptor-dependent mechanisms that limit their expansion. 196
Methotrexate in juvenile idiopathic arthritis: advice and recommendations from the MARAJIA expert consensus meeting 192
Does switching anti-TNFα biologic agents represent an effective option in childhood chronic uveitis: The evidence from a systematic review and meta-analysis approach. 184
Musculin inhibits human T helper 17 cell response to interleukin 2 by controlling STAT5B activity 184
Detection of anti-adalimumab antibodies in a RA responsive cohort of patients using three different techniques 181
Immunosuppressive Activity of Abatacept on Circulating T Helper Lymphocytes from Juvenile Idiopathic Arthritis Patients 179
Bone status of children born from mothers with autoimmune diseases treated during pregnancy with prednisone and/or low molecular weight heparin. 177
Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis. 176
Kawasaki disease: an epidemiological study in central Italy 173
Congenital heart block and immune mediated sensorineural hearing loss: possible cross reactivity of immune response 173
Extracoronary echocardiographic findings as predictors of coronary artery lesions in the initial phase of Kawasaki disease. 173
Demethylation of the RORC2 and IL17A in Human CD4+ T Lymphocytes Defines Th17 Origin of Nonclassic Th1 Cells. 171
Safety and efficacy of infliximab and adalimumab for refractory uveitis in juvenile idiopathic arthritis: 1-year followup data from the Italian Registry. 171
Identification of autoantibodies against inner ear antigens in a cohort of children with idiopathic sensorineural hearing loss. 170
Atypical presentation of anti-N-methyl-D-aspartate receptor encephalitis: Two case reports 170
The expanding spectrum of low-penetrance TNFRSF1A gene variants in adults presenting with recurrent inflammatory attacks: Clinical manifestations and long-term follow-up. 169
Describing Kawasaki shock syndrome: results from a retrospective study and literature review 168
Surface plasmon resonance-based methodology for anti-adalimumab antibody identification and kinetic characterization 167
Kawasaki disease in Sicily: clinical description and markers of disease severity. 165
Methotrexate in juvenile chronic arthritis. 164
Psoriatic juvenile idiopathic arthritis associated with uveitis: a case report. 164
Overexpression of the transmembrane carbonic anhydrase isoforms IX and XII in the inflamed synovium 164
Mycophenolate mofetil as induction and long-term maintaining treatment in childhood: Primary angiitis of the central nervous system 163
Clues to detect tumor necrosis factor receptor-associated periodic syndrome (TRAPS) among patients with idiopathic recurrent acute pericarditis: results of a multicentre study. 162
Inflammatory morphea presenting as a hemifacial acquired port-wine stain 161
Difficult-To-Treat Juvenile Idiopathic Arthritis: Current and Future Options 159
Correction to: The Italian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 158
Idiopathic congenital atrophoderma of Pasini and Pierini 157
Comparing ultraviolet light A photo(chemo)therapy with Methotrexate protocol in childhood localized scleroderma: Evidence from systematic review and meta-analysis approach 156
Eomes controls the development of Th17-derived (non-classic) Th1 cells during chronic inflammation 156
Clinical and transcriptional response to the long-acting interleukin-1 blocker canakinumab in Blau syndrome-related uveitis. 155
Lack of association between the HLA-DRB1 locus and post-streptococcal reactive arthritis and acute rheumatic fever in italian children 154
Systemic Lupus Erythematosus and Bullous Pemphigoid with Dramatic Response to Dapsone 154
Development and Initial Validation of the Macrophage Activation Syndrome/Primary Hemophagocytic Lymphohistiocytosis Score, a Diagnostic Tool that Differentiates Primary Hemophagocytic Lymphohistiocytosis from Macrophage Activation Syndrome 154
A 10-year follow-up of alendronate-treated young patients 153
Anticorpi anti-istone: È sempre lupus indotto da farmaci? 151
Evidence of the transient nature of the Th17 phenotype of CD4+CD161+ T cells in the synovial fluid of patients with juvenile idiopathic arthritis. 150
Epidemiology of Kawasaki disease in Italy: surveillance from national hospitalization records 150
Kawasaki disease in infants less than one year of age: An Italian cohort from a single center 150
The Italian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 150
Flares after withdrawal of biologic therapies in juvenile idiopathic arthritis: Clinical and laboratory correlates of remission duration 147
Joint pain management in children and adolescents 147
Health related quality of life measure in systemic pediatric rheumatic diseases and its translation to different languages: An international collaboration 145
Partial Rescue of Biochemical Parameters After Hematopoietic Stem Cell Transplantation in a Patient with Prolidase Deficiency Due to Two Novel PEPD Mutations. 145
Bone mass predictors in a large cohort of children with juvenile idiopathic arthritis (JIA) 145
Treating juvenile idiopathic arthritis to target: recommendations of an international task force 145
Pediatric Osteoporosis: Diagnosis and Treatment Considerations 144
Th17 and Th1 lymphocytes in oligoarticular juvenile idiopathic arthritis 144
Clonally expanded PD-1-expressing T cells are enriched in synovial fluid of juvenile idiopathic arthritis patients 143
Canakinumab for the treatment of TNF-receptor associated periodic syndrome 143
A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial). 142
Clinical features and outcome of Cogan syndrome. 142
Mucopolysaccharidoses. 141
Childhood uveitis 141
Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis 139
Evidence of a Transient Nature of the th17 Phenotype of cd4+cd161+t Cells in the Synovial Fluid From Patients with Juvenile Idiopathic Arthritis 138
Common variable immunodeficiency presenting as sarcoidosis in a 9-year-old child 138
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study 137
Successful treatment with canakinumab of a paediatric patient with resistant Behçet's disease 137
Association of low bone mass with vitamin d receptor gene and calcitonin receptor gene polymorphisms in juvenile idiopathic arthritis. 136
Glucocorticoids in the management of systemic juvenile idiopathic arthritis. 136
Erratum to: Successful treatment with adalimumab for severe multifocal choroiditis and panuveitis in presumed (early-onset) ocular sarcoidosis 135
Recurrent Pericarditis In Children and Adolescents: Etiology, Presentation, Therapies, and Outcomes In a Multicenter Retrospective Cohort Of 100 Patients. 135
How advances in personalized medicine will change rheumatology 135
The diagnostic evaluation of patients with potential adult-onset autoinflammatory disorders: Our experience and review of the literature. 135
Anti-TNF agents for the treatment of JIA-related Refractory Uveitis: 2010 UPDATE from the Italian Registry 135
Sex Differences in Pediatric Rheumatology 134
The common NOD2/CARD15 variant P268S in patients with non-infectious uveitis: a cohort study 134
Predictors of Relapse after Discontinuing Systemic Treatment in Childhood Autoimmune Chronic Uveitis 134
A boy with bizarre hands mimicking an inflammatory chronic disease. 134
Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease. 134
Current evidence of methotrexate efficacy in childhood chronic uveitis: a systematic review and meta-analysis approach. 133
Biological treatments in behçet's disease: Beyond anti-TNF therapy 133
AB1025 Chronic Recurrent Multifocal Osteomyelitis (CRMO): The Importance of an Accurate Differential Diagnosis 132
Serum amyloid-A in Behçet's disease. 132
How I treat juvenile idiopathic arthritis: A state of the art review 132
Sequential MR angiography in childhood primary angiitis of the CNS. 132
The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation: a series of 158 cases from the Eurofever/EUROTRAPS international registry. 131
Cross-sectional and longitudinal evaluation of bone mass in children and young adults with juvenile idiopathic arthritis: the role of bone mass determinants in a large cohort of patients. 130
Early predictors of juvenile sacroiliitis in enthesitis-related arthritis. 129
Idiopathic calcinosis in a paediatric patient 129
Alterations in the immune system of children from mothers treated with immunosuppressive agents during pregnancy. 128
Totale 16.557
Categoria #
all - tutte 152.411
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 152.411


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.141 0 0 0 0 143 351 125 242 332 410 250 288
2021/20223.007 115 333 234 160 87 129 92 254 151 89 327 1.036
2022/20237.742 955 1.820 258 524 539 1.439 846 351 587 33 257 133
2023/20242.103 101 342 515 132 129 323 63 287 42 59 69 41
2024/202514.892 727 1.837 1.097 2.369 4.172 1.356 246 803 1.050 388 470 377
2025/20267.648 1.634 2.514 1.156 1.366 978 0 0 0 0 0 0 0
Totale 50.147